➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
Dow
Express Scripts
Johnson and Johnson
Moodys

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

BETAMETHASONE VALERATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Betamethasone Valerate, and what generic alternatives are available?

Betamethasone Valerate is a drug marketed by Perrigo Uk Finco, Riconpharma Llc, Taro, Fougera Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Anima, Teva Pharms, and Actavis Mid Atlantic. and is included in eighteen NDAs.

The generic ingredient in BETAMETHASONE VALERATE is betamethasone valerate. There are sixty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.

US ANDA Litigation and Generic Entry Outlook for Betamethasone Valerate

A generic version of BETAMETHASONE VALERATE was approved as betamethasone valerate by FOUGERA PHARMS INC on August 31st, 1983.

  Start Trial

Drug patent expirations by year for BETAMETHASONE VALERATE
Drug Prices for BETAMETHASONE VALERATE

See drug prices for BETAMETHASONE VALERATE

Recent Clinical Trials for BETAMETHASONE VALERATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of SheffieldPhase 2
Sheffield Teaching Hospitals NHS Foundation TrustPhase 2
Association pour la Recherche Clinique et ImmunologiqueN/A

See all BETAMETHASONE VALERATE clinical trials

Pharmacology for BETAMETHASONE VALERATE
Medical Subject Heading (MeSH) Categories for BETAMETHASONE VALERATE
Paragraph IV (Patent) Challenges for BETAMETHASONE VALERATE
Tradename Dosage Ingredient NDA Submissiondate
LUXIQ AEROSOL, FOAM;TOPICAL betamethasone valerate 020934 2007-08-10

US Patents and Regulatory Information for BETAMETHASONE VALERATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo Uk Finco BETAMETHASONE VALERATE betamethasone valerate AEROSOL, FOAM;TOPICAL 078337-001 Nov 26, 2012 AB RX No No   Start Trial   Start Trial   Start Trial
Pharmafair BETAMETHASONE VALERATE betamethasone valerate OINTMENT;TOPICAL 070486-001 May 29, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Pharmafair BETAMETHASONE VALERATE betamethasone valerate CREAM;TOPICAL 070485-001 May 29, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Fougera Pharms Inc BETAMETHASONE VALERATE betamethasone valerate CREAM;TOPICAL 018861-001 Aug 31, 1983 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Pharmafair BETAMETHASONE VALERATE betamethasone valerate LOTION;TOPICAL 070484-001 May 29, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Taro BETAMETHASONE VALERATE betamethasone valerate CREAM;TOPICAL 070062-001 May 14, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
McKesson
AstraZeneca
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.